BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24842918)

  • 1. Adaptor protein p66(Shc) mediates hypertension-associated, cyclic stretch-dependent, endothelial damage.
    Spescha RD; Glanzmann M; Simic B; Witassek F; Keller S; Akhmedov A; Tanner FC; Lüscher TF; Camici GG
    Hypertension; 2014 Aug; 64(2):347-53. PubMed ID: 24842918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells.
    Shi Y; Cosentino F; Camici GG; Akhmedov A; Vanhoutte PM; Tanner FC; Lüscher TF
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2090-7. PubMed ID: 21817106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress.
    Camici GG; Schiavoni M; Francia P; Bachschmid M; Martin-Padura I; Hersberger M; Tanner FC; Pelicci P; Volpe M; Anversa P; Lüscher TF; Cosentino F
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5217-22. PubMed ID: 17360381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species.
    Vikram A; Kim YR; Kumar S; Naqvi A; Hoffman TA; Kumar A; Miller FJ; Kim CS; Irani K
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2301-9. PubMed ID: 25147340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes.
    Paneni F; Mocharla P; Akhmedov A; Costantino S; Osto E; Volpe M; Lüscher TF; Cosentino F
    Circ Res; 2012 Jul; 111(3):278-89. PubMed ID: 22693349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury.
    Spescha RD; Shi Y; Wegener S; Keller S; Weber B; Wyss MM; Lauinger N; Tabatabai G; Paneni F; Cosentino F; Hock C; Weller M; Nitsch RM; Lüscher TF; Camici GG
    Eur Heart J; 2013 Jan; 34(2):96-103. PubMed ID: 23008506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFα signals via p66(Shc) to induce E-Selectin, promote leukocyte transmigration and enhance permeability in human endothelial cells.
    Laviola L; Orlando MR; Incalza MA; Caccioppoli C; Melchiorre M; Leonardini A; Cignarelli A; Tortosa F; Labarbuta R; Martemucci S; Pacelli C; Cocco T; Perrini S; Natalicchio A; Giorgino F
    PLoS One; 2013; 8(12):e81930. PubMed ID: 24349153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes.
    Paneni F; Costantino S; Castello L; Battista R; Capretti G; Chiandotto S; D'Amario D; Scavone G; Villano A; Rustighi A; Crea F; Pitocco D; Lanza G; Volpe M; Del Sal G; Lüscher TF; Cosentino F
    Eur Heart J; 2015 Apr; 36(13):817-28. PubMed ID: 24801072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.
    Spescha RD; Klohs J; Semerano A; Giacalone G; Derungs RS; Reiner MF; Rodriguez Gutierrez D; Mendez-Carmona N; Glanzmann M; Savarese G; Kränkel N; Akhmedov A; Keller S; Mocharla P; Kaufmann MR; Wenger RH; Vogel J; Kulic L; Nitsch RM; Beer JH; Peruzzotti-Jametti L; Sessa M; Lüscher TF; Camici GG
    Eur Heart J; 2015 Jul; 36(25):1590-600. PubMed ID: 25904764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p66(Shc)-induced redox changes drive endothelial insulin resistance.
    Paneni F; Costantino S; Cosentino F
    Atherosclerosis; 2014 Oct; 236(2):426-9. PubMed ID: 25150941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production.
    Wassmann S; Laufs U; Stamenkovic D; Linz W; Stasch JP; Ahlbory K; Rösen R; Böhm M; Nickenig G
    Circulation; 2002 Apr; 105(17):2083-91. PubMed ID: 11980689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells.
    Natalicchio A; Tortosa F; Labarbuta R; Biondi G; Marrano N; Carchia E; Leonardini A; Cignarelli A; Bugliani M; Marchetti P; Fadini GP; Giorgio M; Avogaro A; Perrini S; Laviola L; Giorgino F
    Diabetologia; 2015 Jun; 58(6):1260-71. PubMed ID: 25810038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
    Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
    Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic stretch-induced reactive oxygen species generation enhances apoptosis in retinal pericytes through c-jun NH2-terminal kinase activation.
    Suzuma I; Murakami T; Suzuma K; Kaneto H; Watanabe D; Ojima T; Honda Y; Takagi H; Yoshimura N
    Hypertension; 2007 Feb; 49(2):347-54. PubMed ID: 17159082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced age-dependent cerebrovascular dysfunction is mediated by adaptor protein p66Shc.
    Shi Y; Savarese G; Perrone-Filardi P; Lüscher TF; Camici GG
    Int J Cardiol; 2014 Aug; 175(3):446-50. PubMed ID: 25012499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats.
    Usui T; Okada M; Hara Y; Yamawaki H
    Hypertension; 2012 Oct; 60(4):1031-9. PubMed ID: 22868392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury.
    Carpi A; Menabò R; Kaludercic N; Pelicci P; Di Lisa F; Giorgio M
    Biochim Biophys Acta; 2009 Jul; 1787(7):774-80. PubMed ID: 19362067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation.
    Virdis A; Bacca A; Colucci R; Duranti E; Fornai M; Materazzi G; Ippolito C; Bernardini N; Blandizzi C; Bernini G; Taddei S
    Hypertension; 2013 Aug; 62(2):337-44. PubMed ID: 23734008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension.
    Wong WT; Tian XY; Chen Y; Leung FP; Liu L; Lee HK; Ng CF; Xu A; Yao X; Vanhoutte PM; Tipoe GL; Huang Y
    Circ Res; 2010 Oct; 107(8):984-91. PubMed ID: 20724703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesamin enhances nitric oxide bioactivity in aortas of spontaneously hypertensive rats.
    Kong X; Li W; Guo LQ; Zhang JX; Chen XP; Liu WY; Yang JR
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):314-24. PubMed ID: 26037786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.